Tonix Pharmaceuticals to Participate in the Stifel 2025 Healthcare Conference GlobeNewswire
Market data is delayed by at least 15 minutes.
    Latest Story
    Tonix Pharmaceuticals to Participate in the Stifel 2025 Healthcare Conference
     GlobeNewswire
    Full Story →

    Headline News
    Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Advance Phase 2 Clinical Trial of Dimeric Fc-modified anti-CD40L mAb, TNX-1500, to Prevent Kidney Transplant Organ Rejection
    7:00a ET November 4 '25 GlobeNewswire
    Tonix Pharmaceuticals Announces Presentation at BIO-Europe 2025
    7:00a ET October 28 '25 GlobeNewswire
    Tonix Pharmaceuticals Presented Data on Tonmya(TM) (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence
    7:00a ET October 27 '25 GlobeNewswire
    More News →
    Day  2.51%Week  2.19%Month  23.20%More Charting →
    Today, 12:45p ET Thursday November 6 '25. Markets Open.
    Last $17.67
    Day change   2.51%$0.46
    Open $18.11
    Gap at open $0.01
    Previous close $18.12
    Trading volume 323,328
    10 Day avg vol. 653,539
    Shares out. 11.5Mil
    Market cap. $202.7Mil
    Trading activity Below Avg.
    Previous data from yesterday, November 5 '25.

    Historical Price Performance
    3 month   62.00% 
    6 month   6.19% 
    1 year   26.18% 
    2 year   98.87% 

    Earnings
    Previous 12m -$39.40
    Next 12m Estimate -$13.13
    P/E ratio --
    Revenue 10Mil

    Market data provided by News provided by